Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$21.58 - $29.5 $107 - $147
-5 Reduced 2.11%
232 $6,000
Q3 2022

Oct 21, 2022

SELL
$43.66 - $61.0 $87 - $122
-2 Reduced 0.84%
237 $13,000
Q4 2021

Jan 19, 2022

BUY
$88.71 - $120.43 $14,548 - $19,750
164 Added 218.67%
239 $24,000
Q3 2021

Nov 01, 2021

BUY
$98.77 - $132.17 $7,407 - $9,912
75 New
75 $9,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.